SCHEMBL21036067

SCHEMBL21036067

c1ccc2c(c1)sc1ccc(-c3ccc(-c4ccc5c(c4)c4ccccc4c4c6ccccc6c6ccccc6c54)c4ccccc34)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.47
MAPT P10636 5/20 0.43
ALDH1A1 P00352 3/20 0.43
RAB9A P51151 2/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALOX5 P09917 1/20 0.41
TDP1 Q9NUW8 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
POLB P06746 2/20 0.38
CYP1A2 P05177 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
KDM4E B2RXH2 2/20 0.36
DUSP3 P51452 2/20 0.35
PTPN7 P35236 1/20 0.35
PTPN12 Q05209 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.35
F9 P00740 1/20 0.35
PIM3 Q86V86 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21036068 0.95 ALOX5 (0.47) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL21035232 0.94 PIM3 (0.43) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL21036040 0.93 ALDH1A1 (0.47) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL21035259 0.91 GPR3 (0.52) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL21035261 0.91 GPR3 (0.52) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL25081664 0.90 GPR3 (0.50) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL21036065 0.90 GPR3 (0.50) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL16133148 0.90 GPR3 (0.50) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL21036070 0.90 F9 (0.43) GPR3MAPTALDH1A1RAB9AHPGD
SCHEMBL21035267 0.89 ALOX5 (0.47) GPR3MAPTALDH1A1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, LGR4, OR51E2 GPR3 1218/4885MAPT 2709/4885ALDH1A1 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.